Osteoporosis, bone & mineral

Association between fatty liver index and controlled attenuation parameters as markers of metabolic dysfunction-associated fatty liver disease and bone mineral density: observational and two-sample Mendelian randomization studies

Osteoporos IntPublished Observational and two-sample Mendelian randomization study

Authors' conclusion

No causal effect of MAFLD and hepatic steatosis on BMD was observed in this study, while some metabolic factors were correlated with BMD. This has important implications for understanding the relationship between fatty liver disease and BMD, which may help direct the clinical management of MAFLD patients with osteoporosis.

Study context

Population
UK Biobank and National Health and Nutrition Examination Survey (NHANES) participants
Exposure
MAFLD and hepatic steatosis vs bone mineral density (BMD)
Outcome
Association of MAFLD and steatosis with BMD
Methodological detailsUK Biobank and NHANES datasets, genome-wide association analysis
  • UK Biobank and NHANES datasets
  • Genome-wide association analysis

Main finding

As reported in the abstract

  • Adjusted for demographics and BMI, MAFLD significantly associated with reduced heel BMD; association disappeared after adjusting for additional metabolic factors
  • MAFLD not associated with total body, femur neck and lumbar BMD (NHANES)
  • MRI-measured steatosis not significantly associated with reduced total body, femur neck and lumbar BMD in multivariate analysis
  • Two-sample Mendelian randomization (TSMR): MAFLD and hepatic steatosis not associated with BMD

Observational data: associations, not effects.

Further findings

MAFLD-related comorbid factors and BMD (TSMR)

Overweight and T2D showed a causal relationship with increased BMD; waist circumference and hyperlipidemia had the opposite effect

Original publication

Association between fatty liver index and controlled attenuation parameters as markers of metabolic dysfunction-associated fatty liver disease and bone mineral density: observational and two-sample Mendelian randomization studies. Osteoporos Int. Published 15 January 2024. doi:10.1007/s00198-023-06996-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.